/IVVD

Invivyd Inc

IVVD

$0.79USD↑+1.24%+0.01 today

MARKET CAP

231.5M

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$1 – $1

52W RANGE

$1

$3

AI Summary

Stalk

Sell NowHigh

The stock IVVD is in a Stage 4 decline with a confirmed series of lower highs and lower lows below declining EMAs, supported by distribution volume dominance. Medium-term directional bias is bearish, and near-term pullbacks into the 9/21 EMAs create favorable sell-side entry opportunities. While RSI shows extreme oversold readings, the lack of mean-reversion eligibility and failure of rallies at EMAs suggest downward momentum remains intact. We recommend immediate bearish engagement at resistance zones around the 9/21 EMAs.

↑Pemgarda net revenue rose 21% YoY to $14.3M in Q2 2026.
↑$226.7M cash position supports Phase III VYD2311 trial.
↓FDA flagged mixed third-party data in Pemgarda fact sheet.

Full analysis →

Buying

6

institutions

Selling

6

institutions

New Positions

0

this quarter

Filing Period

Q1 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
JH Janus Henderson Group Plc Q1 2026	BUY	66.19 M	85.71 M	+33.65 M	+6.0%	0.02%
PA Perceptive Advisors LLC Q2 2026	SELL	18.49 M	16.13 M	+-23.23 M	-70.3%	0.24%
BI Blackrock, Inc. Q2 2026	BUY	16.13 M	14.08 M	+11.85 M	+152.9%	0.00%
PA Point72 Asset Management, L.P. Q2 2026	BUY	7.54 M	6.58 M	+7.50 M	+11421.1%	0.01%
AC Adar1 Capital Management, LLC Q2 2026	SELL	3.81 M	3.32 M	+-15.00 K	-33.2%	0.15%
CA Citadel Advisors LLC Q2 2026	BUY	3.77 M	3.29 M	+2.09 M	+50.4%	0.00%
EP Eversept Partners, LP Q2 2026	SELL	2.24 M	1.95 M	+-39.33 K	-34.0%	0.10%
MM Millennium Management LLC Q2 2026	SELL	1.21 M	1.05 M	+-2.31 M	-77.0%	0.00%
RT Renaissance Technologies LLC Q2 2026	BUY	995.33 K	868.33 K	+149.07 K	-21.1%	0.00%
JC Jpmorgan Chase & Co Q2 2026	BUY	109.26 K	103.11 K	+87.73 K	+302.4%	0.00%
BA Balyasny Asset Management L.P. Q2 2026	SELL	0.00	0.00	+-3.52 M	-100.0%	0.00%
BH Brevan Howard Capital Management LP Q2 2026	SELL	0.00	0.00	+-339.58 K	-100.0%	0.00%